首页|期刊导航|中国药业|基于HACCP理论的临床试验质量控制体系探索

基于HACCP理论的临床试验质量控制体系探索OA

Exploration of A Clinical Trial Quality Control System Based on HACCP Theory

中文摘要英文摘要

目的 进一步优化临床试验质量控制体系.方法 基于危害分析与关键控制点(HACCP)理论建立小组,经讨论初步确定质量管理体系的关键点并采用Delphi法进行 2 轮探讨,明确HACCP的范围、目标和进度.小组讨论总结出临床试验质量管理的 6 个流程,经危害分析(HA)确定临床试验管理流程中的关键控制点(CCP),探索临床试验的闭环式管理路径.结果 找到了临床试验管理流程中的 9 项CCP,并针对性建立事前预防、事中监测、事后干预的机制,通过对CCP的监控要求、纠正措施及验证程序的制订,实现临床试验的闭环式管理.结论 该研究中建立了以预防为主的临床试验质量控制体系,一定程度上预防并减少了临床试验质量控制事件的发生,对于提升临床试验的质量及标准化有重要意义.

Objective To further optimize the clinical trial quality control system.Methods Based on the hazard analysis and Critical Control Point(HACCP)theory,a team was established.After discussion,the key points of the quality management system were preliminarily identified,and two rounds of Delphi method were conducted to clarify the scope,objectives,and progress of HACCP.The team discussion summarized six processes for clinical trial quality management,and critical control points(CCPs)in the clinical trial management process were identified through hazard analysis(HA),and a closed-loop management path for clinical trials was explored.Results Nine CCPs in the clinical trial management process were identified,and mechanisms for pre-event prevention,in-event monitoring,and post-event intervention were established accordingly.By formulating monitoring requirements,corrective measures,and verification procedures for CCPs,a closed-loop management for clinical trials was achieved.Conclusion This study established a prevention-oriented clinical trial quality control system,which can partly prevent and reduce the occurrence of clinical trial quality control incidents,and is of great significance for improving the quality and standardization of clinical trials.

钱春艳;李洁;杨能;方莉;程海霞

江苏省常州市第一人民医院,江苏 常州 213003江苏省常州市第一人民医院,江苏 常州 213003江苏省常州市第一人民医院,江苏 常州 213003江苏省常州市第一人民医院,江苏 常州 213003江苏省常州市第一人民医院,江苏 常州 213003

医药卫生

临床试验质量控制危害分析与关键控制点药事管理

clinical trialquality controlHACCPpharmaceutical administration

《中国药业》 2026 (2)

45-49,5

江苏省医院协会医院管理创新研究课题面上项目[JSYGY-3-2021-664]江苏省常州市第七批科技计划项目[CJ20242030]江苏省药学会-奥赛康医院药学科研基金重点项目[A202403].

10.3969/j.issn.1006-4931.2026.02.009

评论